US90308A - Improved medical compound - Google Patents

Improved medical compound Download PDF

Info

Publication number
US90308A
US90308A US90308DA US90308A US 90308 A US90308 A US 90308A US 90308D A US90308D A US 90308DA US 90308 A US90308 A US 90308A
Authority
US
United States
Prior art keywords
improved medical
medical compound
ounce
ounces
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Publication date
Application granted granted Critical
Publication of US90308A publication Critical patent/US90308A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01GPRELIMINARY TREATMENT OF FIBRES, e.g. FOR SPINNING
    • D01G11/00Disintegrating fibre-containing articles to obtain fibres for re-use
    • D01G11/04Opening rags to obtain fibres for re-use
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • This medicine is intended for dysentery, cholera, diarrhma, and other similar bowel-complaints, and is made up of the following elements, in the proportions substantially as named:

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Textile Engineering (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

time gem Letters Patent No. 90,308, dated May 18, 1869.
IIVIPROVED MEDICAL COMPOUND.
The Bc'nedule referred to in these Letters Patent and making part of the same.
To all whom 'it may concern:
Be it known that I, EVANS ROBINSON, of Fail-port, in the county of Monroe, and State of New York, haveinventcd a certain new and improved Medical Gompound; and I do hereby declare that the following is a full and exact description thereof.
This medicine is intended for dysentery, cholera, diarrhma, and other similar bowel-complaints, and is made up of the following elements, in the proportions substantially as named:
For one gallon of the sirup, take, of Turkey rhubarb, one ounce; golden seal, one ounce; nutmeg, two ounces; cinnamon, two ounces; cloves, two ounces. Pulverize finely, and steep, in a cloth bag, three hours, in three quarts of water. Strain, and add six pounds of loaf-sugar. Bring to a scalding heat; cool, and add, saleratus, one ounce; essence peppermint, one ounce; laudanum, one-half ounce; tincture capsicum, one.- balf ounce; best French brandy, one quart.
Some of these elements are in well-known use in medicines for action on the bowels, such, for instance, as rhubarb, laudanum, and brandy. I do not claim these broadly, but only the combination with them of the other parts named, which combination, as a whole, I believe to be new.
' The object to be avoided is a too sudden check to the bowels, which is usually produced by the astringentmedicines now in use. For this reason, I combine, with the astringents, the mild cathartics and tonics, which gradually purge, while they, at the same time, strengthen and heal. That this composition acts in this way, I have tested by practice, and know to be.
US90308D Improved medical compound Expired - Lifetime US90308A (en)

Publications (1)

Publication Number Publication Date
US90308A true US90308A (en) 1869-05-18

Family

ID=2159787

Family Applications (1)

Application Number Title Priority Date Filing Date
US90308D Expired - Lifetime US90308A (en) Improved medical compound

Country Status (1)

Country Link
US (1) US90308A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670264A (en) * 1984-11-14 1987-06-02 International Flavors & Fragrances Inc. Method of causing the reduction of physiological and/or subjective reactivity to stress in humans being subjected to stress conditions
US4670463A (en) * 1984-11-14 1987-06-02 Yale University Method of causing the reduction of physiological and/or subjective reactivity to stress in humans being subjected to stress conditions
US4671959A (en) * 1984-11-14 1987-06-09 Yale University Method of causing the reduction of physiological and/or subjective reactivity to stress in humans being subjected to stress conditions

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670264A (en) * 1984-11-14 1987-06-02 International Flavors & Fragrances Inc. Method of causing the reduction of physiological and/or subjective reactivity to stress in humans being subjected to stress conditions
US4670463A (en) * 1984-11-14 1987-06-02 Yale University Method of causing the reduction of physiological and/or subjective reactivity to stress in humans being subjected to stress conditions
US4671959A (en) * 1984-11-14 1987-06-09 Yale University Method of causing the reduction of physiological and/or subjective reactivity to stress in humans being subjected to stress conditions

Similar Documents

Publication Publication Date Title
US90308A (en) Improved medical compound
US93209A (en) Improved medical compound or
US74940A (en) rambaut
US257029A (en) Medical compound
US102980A (en) Improved medical compound
US82541A (en) George mohler
US81122A (en) Improved medical compound
US203965A (en) Improvement in medical compounds
US67657A (en) Improved medical compound
US95376A (en) Improved compound for the cure of cholera-morbus
US118714A (en) Improvement in medical compounds
US117338A (en) Improvement in medical compounds for liver and other diseases
US65302A (en) Improved medical compound
US80718A (en) Imil frese
US210477A (en) Improvement in medical compounds
US98400A (en) Improved salve
US74205A (en) Chaeles a
US89039A (en) Improved medicine for purifying the blood
US116530A (en) Improvement in medical compounds for cure of cancer and other diseases
US121904A (en) Improvement in medicau compounds fortreating constipation,gc
US98959A (en) Improved medical compound
US116310A (en) Improvement in medical compounds or bitters
US95298A (en) Improved medical compound
US55898A (en) Improved medicine to cure cholera
US92086A (en) Improved medical compound